Heparin cofactor II in patients with deep venous thrombosis under heparin and oral anticoagulant therapy.
Toulon
P
P
Laboratoire d'Hémostase, Hôpital Broussais, Paris, France.
Vitoux
J F
JF
Capron
L
L
Roncato
M
M
Fiessinger
J N
JN
Aiach
M
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000627:therapeutic use*; D000990:Antithrombin III / Q000032:analysis; D000991:Antithrombins / Q000032:analysis*; D005260:Female; D006023:Glycoproteins / Q000097:blood*; D006493:Heparin / Q000627:therapeutic use*; D015844:Heparin Cofactor II; D006801:Humans; D008297:Male; D008875:Middle Aged; D013924:Thrombophlebitis / Q000097:blood* / Q000188:drug therapy
D000925:Anticoagulants; D000991:Antithrombins; D006023:Glycoproteins; D015844:Heparin Cofactor II; D000990:Antithrombin III; D006493:Heparin